Financials
Financial year 2024
Worth noting
- A loss two years in a row.
Gross margin
€ -125,098
▼ 96% vs 2023
Profit
Caution€ -183,907
▼ 18% vs 2023
Debts
Normal€ 442,897
▲ 4% vs 2023
ASYLIA DIAGNOSTICS from Leuven, company number BE0732783629, closed financial year 2024 with a result of € -183,907 after tax. For that financial year ASYLIA DIAGNOSTICS recorded a gross margin of € -125,098 and equity of € 109,193. Compared with financial year 2023, the result moved from € -155,958 to € -183,907. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2025.
What happened at ASYLIA DIAGNOSTICS?
What happened at ASYLIA DIAGNOSTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 183,907. Source: NBB ↗
- New establishment in Leuven. KBO
- Andrey KHMELEVSKIY became a director. NBB
- PHARMALEGAL BV became a director. NBB
- Anna KOSTIKOVA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 141,494 loss in 2021 to € 183,907 loss in 2024.
Best year ever: 2022, with € 75,602 profit.
A new publication or filing at ASYLIA DIAGNOSTICS? We notify you, reason included.
Follow ASYLIA DIAGNOSTICSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ASYLIA DIAGNOSTICS are Andrey KHMELEVSKIY, PHARMALEGAL BV and Anna KOSTIKOVA. The same people are also behind ZORGPUNT, Lynxcare Clinical Informatics, Curaevia, Thuiszorg Cooperatie and PharmaBXL.
Directors
According to the 2024 annual accounts
Andrey KHMELEVSKIY
Director
since 2019
Director · represented by DE FEU Georges
Also active at: ZORGPUNT, Lynxcare Clinical Informatics, Curaevia +3 more
since 2019
Anna KOSTIKOVA
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Philipssite 5 box 1
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 88 companies are registered at this address.
Norgine
€ 19.1 million revenue · 2024
DRAKA BELGIUM
€ 3.4 million revenue · 2025
LOFMA
€ 1.8 million gross margin · 2025
G.I.M. - GEOGRAPHIC INFORMATION MANAGEMENT
€ 7.1 million revenue · 2025
ADVOCATENASSOCIATIE NELISSEN GRADE
€ 477,864 gross margin · 2025
+83 more
Details
- Company number
- 0732.783.629
- VAT number
- BE 0732.783.629
- Registered office
- Philipssite 5 bus 1, 3001 Leuven
- Names & denominations
- ASYLIA DIAGNOSTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 August 2019
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied